Developed by Shray Alag, The Harker School
Sections: Correlations,
Clinical Trials, and HPO
Navigate: Clinical Trials and HPO
| Name (Synonyms) | Correlation | |
|---|---|---|
| drug1283 | Duodenal biopsy Wiki | 1.00 |
| drug1174 | Deep Breathing training Wiki | 1.00 |
| drug3513 | Saliva Wiki | 1.00 |
| Name (Synonyms) | Correlation | |
|---|---|---|
| D017250 | Caliciviridae Infections NIH | 0.71 |
| D003141 | Communicable Diseases NIH | 0.07 |
| D007239 | Infection NIH | 0.05 |
| Name (Synonyms) | Correlation |
|---|
Navigate: Correlations HPO
There is one clinical trial.
The present study investigates the efficacy of a brief and cost-effective video-intervention that combines bottom-up elements of deep breathing and third-wave cognitive behavioral therapy techniques (i.e., mindfulness and compassion) on coping strategies during the COVID-19 pandemic.
Description: Perseverative cognition measured as frequency score. Minimum score = 0 Maximum score = 28. Higher scores mean a worse outcome.
Measure: Dispositional questionnaire 1 Time: During waking hours for two consecutive days before the intervention/control conditionDescription: Perseverative cognition measured as frequency score. Minimum score = 0 Maximum score = 28. Higher scores mean a worse outcome.
Measure: Dispositional questionnaire 1 Time: During waking hours for two consecutive days after the intervention/control conditionDescription: Effective coping strategies measured as frequency score. Minimum score = 0 Maximum score = 28. Higher scores mean a better outcome.
Measure: Dispositional questionnaire 2 Time: During waking hours for two consecutive days after the intervention/control conditionDescription: Mood state measured as score on a Likert scale. Minimum score = 1 Maximum score = 5. Higher scores mean a worse outcome.
Measure: Dispositional questionnaire 3 Time: During waking hours for two consecutive days before the intervention/control conditionDescription: Mood state measured as score on a Likert scale. Minimum score = 1 Maximum score = 5. Higher scores mean a worse outcome.
Measure: Dispositional questionnaire 3 Time: During waking hours for two consecutive days after the intervention/control conditionDescription: Emotional state measured as score on a Likert scale. Minimum score = 1 Maximum score = 5. Higher scores mean a worse outcome.
Measure: Dispositional questionnaire 4 Time: During waking hours for two consecutive days before the intervention/control conditionDescription: Emotional state measured as score on a Likert scale. Minimum score = 1 Maximum score = 5. Higher scores mean a worse outcome.
Measure: Dispositional questionnaire 4 Time: During waking hours for two consecutive days after the intervention/control conditionDescription: Heart rate (measured in beats per minute) recorded via a smartphone application
Measure: Heart rate Time: During waking hours for two consecutive days before the intervention/control conditionDescription: Heart rate (measured in beats per minute) recorded via a smartphone application
Measure: Heart rate Time: During waking hours for two consecutive days after the intervention/control conditionDescription: Root mean square of the successive differences (measured in ms) recorded via a smartphone application
Measure: Cardiac vagal modulation Time: During waking hours for two consecutive days before the intervention/control conditionDescription: Root mean square of the successive differences (measured in ms) recorded via a smartphone application
Measure: Cardiac vagal modulation Time: During waking hours for two consecutive days after the intervention/control conditionAlphabetical listing of all HPO terms. Navigate: Correlations Clinical Trials
Data processed on September 26, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.
Drug Reports MeSH Reports HPO Reports